Last 12 months
Inside the activity.
1 purchase rows · 173 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 16 |
| Apr 2026 | 0 | 23 |
| May 2026 | 1 | 24 |
| Jun 2026 | 0 | 37 |
| Jul 2026 | 0 | 33 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 10 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 14,207 | $53.25 | $756,565.37 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 6 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,870,042 F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.03 to $53.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 75,293 | $52.38 | $3,943,538.64 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 5 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,884,249 F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.03 to $53.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 10,500 | $51.31 | $538,762.35 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 4 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,959,542 F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 27,613 | $50.10 | $1,383,491.38 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 3 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,970,042 F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.93 to $50.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 115,479 | $49.45 | $5,709,882.25 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 2 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,997,655 F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.93 to $49.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:30 UTC |
Bloch Stephen MDirector
|
SaleCommon Stock | 75,801 | $48.61 | $3,684,535.01 |
DisclosureSEC source: 0001104659-26-060291 · tm2614500-1_4seq1.xml · nonDerivative · entry 1 Bloch Stephen M · CIK 0001400308 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,113,134 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.93 to $48.925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. The Reporting Person disclaims beneficial ownership of the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC. The Canaan Entities have instituted a communications-screen policy with respect to securities matters relating to the Issuer, and the Reporting Person did not participate in this investment decision. Read SEC document |
| May 08, 2026 Filed May 12, 2026 22:52 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $42.14 | $1,053,565.00 |
DisclosureSEC source: 0001104659-26-059578 · tm2614438-1_4seq1.xml · nonDerivative · entry 3 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,323,095 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $41.08 to $42.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| May 07, 2026 Filed May 7, 2026 22:19 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $42.09 | $1,052,135.00 |
DisclosureSEC source: 0001104659-26-057339 · tm2613988-1_4seq1.xml · nonDerivative · entry 5 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,348,095 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F7 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $41.05 to $42.87. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| May 06, 2026 Filed May 7, 2026 22:19 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $40.78 | $1,019,572.50 |
DisclosureSEC source: 0001104659-26-057339 · tm2613988-1_4seq1.xml · nonDerivative · entry 4 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,373,095 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F6 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.09 to $41.19. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| May 05, 2026 Filed May 7, 2026 22:19 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $40.10 | $1,002,592.50 |
DisclosureSEC source: 0001104659-26-057339 · tm2613988-1_4seq1.xml · nonDerivative · entry 3 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,398,095 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:31 UTC |
Boyle DanaChief Accounting Officer
|
SaleCommon Stock | 1,576 | $37.78 | $59,541.28 |
DisclosureSEC source: 0001104659-26-051579 · tm2613111-2_4seq1.xml · nonDerivative · entry 1 Boyle Dana · CIK 0002074453 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,342 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 25, 2023. F3 · balance_after: Includes (i) 9,375 unvested RSUs of the 50,000 RSUs granted to the Reporting Person on January 25, 2023, (ii) 24,975 unvested RSUs of the 57,085 RSUs granted to the Reporting Person on January 11, 2024, (iii) 34,966 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4, (v) 23,728 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (vi) 3,964 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 27, 2026 Filed Apr 29, 2026 20:30 UTC |
Adair JasonChief Business Officer
|
SaleCommon Stock | 688 | $41.65 | $28,655.20 |
DisclosureSEC source: 0001104659-26-051571 · tm2613111-1_4seq1.xml · nonDerivative · entry 1 Adair Jason · CIK 0001747055 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,738 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F2 · shares: These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on July 6, 2023. F3 · balance_after: Includes (i) 7,812 unvested RSUs of the 25,000 RSUs granted to the Reporting Person on July 6, 2023, (ii) 17,320 unvested RSUs of the 39,588 RSUs granted to the Reporting Person on January 11, 2024, (iii) 42,553 unvested RSUs of the 61,895 RSUs granted to the Reporting Person on January 11, 2025, (iv) 27,683 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 12,023 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 17, 2026 Filed Apr 21, 2026 20:30 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 18,839 | $40.60 | $764,955.71 |
DisclosureSEC source: 0001104659-26-046046 · tm2612297-1_4seq1.xml · nonDerivative · entry 3 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,423,095 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $41.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:38 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $40.31 | $1,007,800.00 |
DisclosureSEC source: 0001104659-26-044512 · tm2612047-2_4seq1.xml · nonDerivative · entry 5 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,441,934 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F6 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.72. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:38 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 25,000 | $40.14 | $1,003,522.50 |
DisclosureSEC source: 0001104659-26-044512 · tm2612047-2_4seq1.xml · nonDerivative · entry 4 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,466,934 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F5 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 86,971 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · derivative · entry 8 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,534 Underlying: Common Stock · 86,971 shares Expires 2030-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested over a four-year period with 25% vesting on November 30, 2021 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on November 30, 2024. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
SaleCommon Stock | 43,375 | $40.14 | $1,741,111.54 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 6 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 353,356 F6 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
SaleCommon Stock | 86,971 | $40.14 | $3,491,094.21 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 5 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,731 F5 · kind: Represents the subsequent sale of the underlying shares from the exercise of stock options on April 15, 2026 reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
Exercise / conversionCommon Stock | 86,971 | $2.79 | $242,649.09 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 4 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 483,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
SaleCommon Stock | 9,044 | $40.14 | $363,034.30 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 3 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 396,731 F3 · kind: Represents the subsequent sale of shares acquired under the ESPP reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:38 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 3,300 | $40.00 | $132,000.00 |
DisclosureSEC source: 0001104659-26-044512 · tm2612047-2_4seq1.xml · nonDerivative · entry 3 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,491,934 F3 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F4 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · derivative · entry 7 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,505 Underlying: Common Stock · 3,000 shares Expires 2030-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vested over a four-year period with 25% vesting on November 30, 2021 and the remaining 75% vesting ratably on a monthly basis over three years thereafter and became fully vested on November 30, 2024. Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
SaleCommon Stock | 3,000 | $40.00 | $120,000.00 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 2 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,775 F2 · kind: Represents the subsequent sale of the underlying shares from the exercise of stock options on April 14, 2026 reported on this Form 4. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 14, 2026 Filed Apr 17, 2026 00:37 UTC |
Kaseta MichaelCFO and COO
|
Exercise / conversionCommon Stock | 3,000 | $2.79 | $8,370.00 |
DisclosureSEC source: 0001104659-26-044511 · tm2612047-1_4seq1.xml · nonDerivative · entry 1 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 408,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan ("ESPP"). Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:05 UTC |
Schundler RussellGeneral Counsel
|
SaleCommon Stock | 13,692 | $38.37 | $525,362.04 |
DisclosureSEC source: 0001104659-26-043264 · tm2611789-2_4seq1.xml · nonDerivative · entry 3 Schundler Russell · CIK 0001854414 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 610,532 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 19,531 unvested restricted stock units ("RSUs") of the 104,167 RSUs granted to the Reporting Person on January 11, 2023, (ii) 48,184 unvested RSUs of the 110,135 RSUs granted to the Reporting Person on January 11, 2024, (iii) 70,498 unvested RSUS of the 102,543 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 12,306 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:06 UTC |
Krepp SarahChief Human Resource Officer
|
SaleCommon Stock | 4,557 | $38.37 | $174,852.09 |
DisclosureSEC source: 0001104659-26-043267 · tm2611789-4_4seq1.xml · nonDerivative · entry 2 Krepp Sarah · CIK 0002074990 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,019 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2024, July 1, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 25,640 unvested RSUs of the 61,465 RSUs granted to the Reporting Person on January 11, 2024, (ii) 7,008 unvested RSUs of the 12,459 RSUs granted to the Reporting Person on July 1, 2024, (iii) 34,966 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4, (v) 23,728 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (vi) 5,749 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:07 UTC |
Boyle DanaChief Accounting Officer
|
SaleCommon Stock | 5,101 | $38.37 | $195,725.37 |
DisclosureSEC source: 0001104659-26-043270 · tm2611789-6_4seq1.xml · nonDerivative · entry 2 Boyle Dana · CIK 0002074453 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,918 F4 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F5 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 12,500 unvested restricted stock units ("RSUs") of the 50,000 RSUs granted to the Reporting Person on January 25, 2023, (ii) 24,975 unvested RSUs of the 57,085 RSUs granted to the Reporting Person on January 11, 2024, (iii) 34,966 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4, (v) 23,728 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (vi) 3,964 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:06 UTC |
Saggar RajeevChief Medical Officer
|
SaleCommon Stock | 9,220 | $38.37 | $353,771.40 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 3 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,270 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 32,744 | $38.37 | $1,256,387.28 |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · nonDerivative · entry 3 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,137,599 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 54,281 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 96,835 unvested RSUs of the 221,338 RSUs granted to the Reporting Person on January 11, 2024, (iii) 157,662 unvested RSUs of the 229,327 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 115,344 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:07 UTC |
Kaseta MichaelCFO and COO
|
SaleCommon Stock | 18,958 | $38.37 | $727,418.46 |
DisclosureSEC source: 0001104659-26-043269 · tm2611789-5_4seq1.xml · nonDerivative · entry 5 Kaseta Michael · CIK 0001724346 · CFO and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,775 F7 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F8 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024, January 15, 2024 and January 11, 2025. F1 · balance_after: Includes (i) 23,375 unvested restricted stock units ("RSUs") of the 124,667 RSUs granted to the Reporting Person on January 11, 2023, (ii) 40,797 unvested RSUs and 21,875 unvested RSUs of the 93,250 RSUs and 50,000 RSUs granted to the Reporting Person on January 11, 2024 and January 15, 2024, respectively, (iii) 77,547 unvested RSUs of the 112,797 RSUs granted to the Reporting Person on January 11, 2025, (iv) 59,320 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 11,694 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:07 UTC |
Adair JasonChief Business Officer
|
SaleCommon Stock | 7,301 | $38.37 | $280,139.37 |
DisclosureSEC source: 0001104659-26-043271 · tm2611789-7_4seq1.xml · nonDerivative · entry 4 Adair Jason · CIK 0001747055 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 215,426 F7 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F8 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 9,375 unvested RSUs of the 25,000 RSUs granted to the Reporting Person on July 6, 2023, (ii) 17,320 unvested RSUs of the 39,588 RSUs granted to the Reporting Person on January 11, 2024, (iii) 42,553 unvested RSUs of the 61,895 RSUs granted to the Reporting Person on January 11, 2025, (iv) 27,683 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 12,023 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:08 UTC |
Moomaw ScottChief Commercial Officer
|
SaleCommon Stock | 1,686 | $38.20 | $64,405.20 |
DisclosureSEC source: 0001104659-26-043274 · tm2611789-8_4seq1.xml · nonDerivative · entry 4 Moomaw Scott · CIK 0001832592 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,558 F7 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 7, 2025. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,754 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 47,938 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:08 UTC |
Moomaw ScottChief Commercial Officer
|
SaleCommon Stock | 8,861 | $38.37 | $339,996.57 |
DisclosureSEC source: 0001104659-26-043274 · tm2611789-8_4seq1.xml · nonDerivative · entry 3 Moomaw Scott · CIK 0001832592 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,244 F5 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. F6 · shares: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024 and January 11, 2025. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 21,754 unvested RSUs of the 49,723 RSUs granted to the Reporting Person on January 11, 2024, (iii) 47,938 unvested RSUs of the 69,729 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,650 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
Schundler RussellGeneral Counsel
|
Exercise / conversionPerformance Stock Units · Derivative | 6,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043264 · tm2611789-2_4seq1.xml · derivative · entry 6 Schundler Russell · CIK 0001854414 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,498 Underlying: Common Stock · 6,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
Schundler RussellGeneral Counsel
|
Exercise / conversionPerformance Stock Units · Derivative | 3,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043264 · tm2611789-2_4seq1.xml · derivative · entry 5 Schundler Russell · CIK 0001854414 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,309 Underlying: Common Stock · 3,758 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
Schundler RussellGeneral Counsel
|
Exercise / conversionCommon Stock | 6,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043264 · tm2611789-2_4seq1.xml · nonDerivative · entry 2 Schundler Russell · CIK 0001854414 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 624,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 102,543 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 32,045 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 19,531 unvested restricted stock units ("RSUs") of the 104,167 RSUs granted to the Reporting Person on January 11, 2023, (ii) 48,184 unvested RSUs of the 110,135 RSUs granted to the Reporting Person on January 11, 2024, (iii) 70,498 unvested RSUS of the 102,543 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 12,306 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
Schundler RussellGeneral Counsel
|
Exercise / conversionCommon Stock | 3,758 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043264 · tm2611789-2_4seq1.xml · nonDerivative · entry 1 Schundler Russell · CIK 0001854414 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 617,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 60,135 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 33,826 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 19,531 unvested restricted stock units ("RSUs") of the 104,167 RSUs granted to the Reporting Person on January 11, 2023, (ii) 48,184 unvested RSUs of the 110,135 RSUs granted to the Reporting Person on January 11, 2024, (iii) 70,498 unvested RSUS of the 102,543 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 12,306 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Krepp SarahChief Human Resource Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 3,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043267 · tm2611789-4_4seq1.xml · derivative · entry 3 Krepp Sarah · CIK 0002074990 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,966 Underlying: Common Stock · 3,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Krepp SarahChief Human Resource Officer
|
Exercise / conversionCommon Stock | 3,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043267 · tm2611789-4_4seq1.xml · nonDerivative · entry 1 Krepp Sarah · CIK 0002074990 · Chief Human Resource Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2025, the Reporting Person was granted 50,861 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 15,895 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 25,640 unvested RSUs of the 61,465 RSUs granted to the Reporting Person on January 11, 2024, (ii) 7,008 unvested RSUs of the 12,459 RSUs granted to the Reporting Person on July 1, 2024, (iii) 34,966 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4, (v) 23,728 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (vi) 5,749 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:07 UTC |
Boyle DanaChief Accounting Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 3,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043270 · tm2611789-6_4seq1.xml · derivative · entry 3 Boyle Dana · CIK 0002074453 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,966 Underlying: Common Stock · 3,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:07 UTC |
Boyle DanaChief Accounting Officer
|
Exercise / conversionCommon Stock | 3,179 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043270 · tm2611789-6_4seq1.xml · nonDerivative · entry 1 Boyle Dana · CIK 0002074453 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2025, the Reporting Person was granted 50,861 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 15,895 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 12,500 unvested restricted stock units ("RSUs") of the 50,000 RSUs granted to the Reporting Person on January 25, 2023, (ii) 24,975 unvested RSUs of the 57,085 RSUs granted to the Reporting Person on January 11, 2024, (iii) 34,966 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4, (v) 23,728 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (vi) 3,964 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Saggar RajeevChief Medical Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · derivative · entry 5 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,349 Underlying: Common Stock · 4,486 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Saggar RajeevChief Medical Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 3,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · derivative · entry 4 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,715 Underlying: Common Stock · 3,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Saggar RajeevChief Medical Officer
|
Exercise / conversionCommon Stock | 4,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 2 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 71,780 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 22,431 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:06 UTC |
Saggar RajeevChief Medical Officer
|
Exercise / conversionCommon Stock | 3,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043265 · tm2611789-3_4seq1.xml · nonDerivative · entry 1 Saggar Rajeev · CIK 0001935638 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 31,777 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 15,625 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 24,715 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 49,349 unvested RSUs of the 71,780 RSUs granted to the Reporting Person on January 11, 2025, (iv) 32,955 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4 and (v) 2,213 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 14,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · derivative · entry 7 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,662 Underlying: Common Stock · 14,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 13,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · derivative · entry 6 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,835 Underlying: Common Stock · 13,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.exercise_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F1 · derivative.expiration_date: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
SaleCommon Stock | 21,433 | $40.12 | $859,876.96 |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · nonDerivative · entry 5 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 1,495,234 F8 · kind: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 5, 2025. F9 · price: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $40.00 to $40.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10 · ownership.nature: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 14,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · nonDerivative · entry 2 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,170,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On January 11, 2025, the Reporting Person was granted 229,327 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 71,665 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 54,281 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 96,835 unvested RSUs of the 221,338 RSUs granted to the Reporting Person on January 11, 2024, (iii) 157,662 unvested RSUs of the 229,327 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 115,344 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:05 UTC |
JEFFS ROGERDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 13,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-043262 · tm2611789-1_4seq1.xml · nonDerivative · entry 1 JEFFS ROGER · CIK 0001231615 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,156,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On January 11, 2024, the Reporting Person was granted 221,338 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 124,503 have vested as of the date of this Form 4. F1 · price: Performance stock units ("PSUs") convert into common stock on a one-for-one basis. F3 · balance_after: Includes (i) 54,281 unvested restricted stock units ("RSUs") of the 289,500 RSUs granted to the Reporting Person on January 11, 2023, (ii) 96,835 unvested RSUs of the 221,338 RSUs granted to the Reporting Person on January 11, 2024, (iii) 157,662 unvested RSUs of the 229,327 RSUs granted to the Reporting Person on January 11, 2025 and (iv) 115,344 RSUs granted to the Reporting Person on January 16, 2026, none of which have vested as of the date of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.